14-Oct-2026 18:03:31

GODAVARIB : GETS US PATENT FOR CANCER TREATMENT COMPOUND

• United States-based patent application titled "5-Hydroxy-1,4-Naphthalenedione for use in the treatment of cancer" has been granted • Patent protects a novel class of compounds that effectively inhibit cancer and cancer stem cells • Compounds show significant potential against various cancer types, including breast and prostate • Grant certificate attached with the disclosure filed under Regulation 30 of SEBI LODR

Godavari Biorefineries Ltd

← Back to feed